welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD

key information

study id #: NCT02515669

condition: Muscular Dystrophy (DMD)

status: terminated


The purpose of this study is to determine the safety and tolerability of RO7239361 in boys with Duchenne Muscular Dystrophy with any genetic mutation.

intervention: RO7239361, Placebo

mechanism of action: Anti-myostatin adnectin to promote muscle growth

results: https://clinicaltrials.gov/ct2/show/results/NCT02515669

last updated: November 13, 2020